New study observes how patients with mantle cell lymphoma fare on modern drugs

NCT ID NCT03816683

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study created a registry of 227 adults with mantle cell lymphoma who had recently started a new type of therapy. Researchers tracked which treatments were used, how long patients stayed on them, and how patients rated their own quality of life. The goal was to gather real-world information, not to test a new drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mantle cell lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MANTLE CELL LYMPHOMA

Contacts and locations

Locations

Research Site

Montgomery, Alabama, 36101, United States
Research Site

Clovis, California, 93611, United States
Research Site

Boulder, Colorado, 80303-1385, United States
Research Site

Jacksonville, Florida, 32256, United States
Research Site

Pensacola, Florida, 32503, United States
Research Site

Tampa, Florida, 33612-9497, United States
Research Site

Atlanta, Georgia, 30322, United States
Research Site

Augusta, Georgia, 30912, United States
Research Site

Chicago, Illinois, 60612, United States
Research Site

Iowa City, Iowa, 52242, United States
Research Site

Ann Arbor, Michigan, 48109, United States
Research Site

Duluth, Minnesota, 55805, United States
Research Site

Saint Louis Park, Minnesota, 55416, United States
Research Site

Saint Paul, Minnesota, 55102, United States
Research Site

Lincoln, Nebraska, 68510, United States
Research Site

Berkeley Heights, New Jersey, 07922, United States
Research Site

Hackensack, New Jersey, 07601, United States
Research Site

East Syracuse, New York, 13057, United States
Research Site

New York, New York, 10022, United States
Research Site

Eugene, Oregon, 97401-8122, United States
Research Site

Danville, Pennsylvania, 17822, United States
Research Site

Philadelphia, Pennsylvania, 19104, United States
Research Site

Philadelphia, Pennsylvania, 19111, United States
Research Site

Nashville, Tennessee, 37232, United States
Research Site

Dallas, Texas, 75231, United States
Research Site

Dallas, Texas, 75390, United States
Research Site

Houston, Texas, 77030, United States
Research Site

San Antonio, Texas, 78229, United States
Research Site

Seattle, Washington, 98122, United States
Research Site

Seattle, Washington, 98195-9472, United States
Research Site

Morgantown, West Virginia, 26506, United States
Research Site

Milwaukee, Wisconsin, 53226, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.